Accessing GLP-1 treatment in Sunnyvale, California has traditionally meant longer waits than mainland patients face. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Sunnyvale address at $329/month. Compounded Tirzepatide is not FDA-approved.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Sunnyvale is already seeing results
Zepbound in Sunnyvale, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Sunnyvale from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Zepbound® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2023. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Sunnyvale, CA residents starts at $329/month.
Hispanic adults in Sunnyvale face disproportionately high rates of obesity and type 2 diabetes — conditions that Tirzepatide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Tirzepatide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) starts at $329/month with no insurance needed. Everything happens virtually from your Sunnyvale home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.